These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1703377)

  • 1. [Clinical trial for treating multiple sclerosis patients with isoprinosine].
    Wielgomas T
    Wiad Lek; 1990 Aug 1-15; 43(15-16):787. PubMed ID: 1703377
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoprinosine in multiple sclerosis treatment: a preliminary study.
    Mazzarello P; Rocchelli B; Poloni M; Delodovici M; Pinelli P
    Schweiz Arch Neurol Neurochir Psychiatr; 1982; 131(2):175-9. PubMed ID: 6187064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isoprinosine treatment of multiple sclerosis. 52 cases].
    Confavreux C; Thivolet C; Ventre JJ; Aimard G; Devic M
    Presse Med; 1986 Dec; 15(45):2256-7. PubMed ID: 2433686
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis.
    Pompidou A; Rancurel G; Delsaux MC; Meunier C; Telvi L; Cour V; Buge A
    Cancer Detect Prev Suppl; 1987; 1():377-83. PubMed ID: 2446758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and immunological improvement of remittent multiple sclerosis by isoprinosine. Randomized pilot study].
    Pompidou A; Rancurel G; Delsaux MC; Telvi L; Cour V; Buge A
    Presse Med; 1986 May; 15(20):930-1. PubMed ID: 2424001
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in visual evoked potentials in patients with multiple sclerosis treated with isoprinosine and amantadine.
    Maciejek Z
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):621-8. PubMed ID: 2484835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.
    Milligan NM; Miller DH; Compston DA
    J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):164-8. PubMed ID: 7510330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective assessment of combined treatment with high doses of intravenous methylprednisolone and long term administration of Isoprinosine in multiple sclerosis patients].
    Maciejek Z; Niezgodzińska-Maciejek A
    Neurol Neurochir Pol; 1993; 27(3):321-9. PubMed ID: 7694166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present status of the protocol for the trial of isoprinosine in the treatment of uveitis].
    Mouillac-Gambarelli N; Weiller PJ; Merlihot JM; Berard PV
    Bull Soc Ophtalmol Fr; 1980 Oct; 80(10):885-7. PubMed ID: 6160920
    [No Abstract]   [Full Text] [Related]  

  • 10. [Attempted therapy of rheumatoid polyarthritis with isoprinosine. Results of an open study of 14 patients].
    Segond P; Sallière D; Clerc D; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1982 Jan; 49(1):45-9. PubMed ID: 6176009
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoprinosine in the therapy of herpes zoster occurring in patients with malignant lymphoproliferative diseases].
    Corridori S; Vender A; Lago A; Cerrato P
    Riv Emoter Immunoematol; 1980; 27(3-4):142-50. PubMed ID: 6176005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of the use of isoprinosine in viral infections].
    Fiori GP
    G Ital Chemioter; 1981; 28(1-2):73-6. PubMed ID: 6182051
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isoprinosine treatment of herpes zoster. Résults of a control study in 36 subjects (author's transl)].
    Lesourd B; Laude J; Meunier P; Doumerc S; Moulias R
    Nouv Presse Med; 1982 Jan; 11(3):191-3. PubMed ID: 6173843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isoprinosine in the treatment of herpes zoster and herpes recurrens].
    Bowszyc J; Janicka D; Silny W; Neumann E; Stepień B
    Przegl Dermatol; 1983; 70(3):283-90. PubMed ID: 6198697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. I. Clinical evaluation].
    Michalska Z; Dubicka M; Nedoszytko B; Gajda A
    Wiad Lek; 1987 Oct; 40(20):1369-74. PubMed ID: 2451357
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
    Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
    Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of an immunomodulant, isoprinosine, in multibacillary leprosy. Preliminary study].
    Saint-André P; Ferracci C; Ridel PR; Baquillon C; Boucher P
    Acta Leprol; 1982; (86-87):113-29. PubMed ID: 6183917
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of treatment of herpes simplex and herpes zoster with isoprinosine].
    Polubiec A; Kołakowska-Polubiec K; Stepka K
    Pol Tyg Lek; 1985 Jan; 40(2):45-6. PubMed ID: 2579368
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of rheumatoid arthritis with isoprinosine. Personal experience].
    Bouvier M; Bonvoisin B; Lejeune E; Sidot C; Touraine JL; Touraine F
    Rev Rhum Mal Osteoartic; 1983 Oct; 50(10):653-7. PubMed ID: 6196834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blind clinical trial of isoprinosine and placebo in herpetic keratitis].
    Haut J; Debrat G; Moulin F; Monin C; Sarnikovski C
    Bull Soc Ophtalmol Fr; 1983 May; 83(5):617-20. PubMed ID: 6200245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.